TD Cowen analyst Charles Rhyee raised the firm’s price target on Cardinal Health (CAH) to $225 from $183 and keeps a Buy rating on the shares. The firm update their estimates following a F1Q26 where the company raised its adj. EPS guide, Pharma guide, and Other AOI guide.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health Reports Strong Earnings and Raises Guidance
- Cardinal Health price target raised to $220 from $190 at Evercore ISI
- Cardinal Health price target raised to $220 from $185 at UBS
- Cardinal Health price target raised to $232 from $208 at Baird
- Cardinal Health price target raised to $190 from $165 at Citi